IMGN | | ImmunoGen, Inc. | Thackray Helen M. | Director | Dec 29, 2023 | Option Exercise | $29.65 | 252 | 7,472 | 3,074 | Jan 03, 2024, 05:42 PM |
BCRX | | BIOCRYST PHARMACEUTICALS INC | Thackray Helen M. | Chief R&D Officer | Dec 19, 2023 | Option Exercise | $6.05 | 5,580 | 33,759 | 249,664 | Dec 20, 2023, 04:42 PM |
BCRX | | BIOCRYST PHARMACEUTICALS INC | Thackray Helen M. | Chief R&D Officer | Dec 14, 2023 | Option Exercise | $6.43 | 3,031 | 19,489 | 255,244 | Dec 18, 2023, 04:47 PM |
IMGN | | ImmunoGen, Inc. | Thackray Helen M. | Director | Sep 29, 2023 | Option Exercise | $15.87 | 472 | 7,491 | 2,822 | Oct 02, 2023, 05:07 PM |
IMGN | | ImmunoGen, Inc. | Thackray Helen M. | Director | Jun 30, 2023 | Option Exercise | $18.87 | 397 | 7,491 | 2,350 | Jul 05, 2023, 05:52 PM |
BCRX | | BIOCRYST PHARMACEUTICALS INC | Thackray Helen M. | Chief R&D Officer | Apr 03, 2023 | Sale | $8.29 | 7,000 | 58,030 | 207,275 | Apr 05, 2023, 04:33 PM |
BCRX | | BIOCRYST PHARMACEUTICALS INC | Thackray Helen M. | Chief R&D Officer | Dec 15, 2022 | Sale | $10.89 | 3,125 | 34,031 | 133,275 | Dec 19, 2022, 04:58 PM |
BCRX | | BIOCRYST PHARMACEUTICALS INC | Thackray Helen M. | Chief R&D Officer | Apr 01, 2022 | Sale | $16.20 | 7,600 | 123,120 | 136,400 | Apr 04, 2022, 04:32 PM |
GLYC | | GLYCOMIMETICS INC | Thackray Helen M. | SVP Clinical Development, CMO | Dec 08, 2017 | Sale | $15.01 | 2,000 | 30,020 | 148,615 | Dec 12, 2017, 04:14 PM |
GLYC | | GLYCOMIMETICS INC | Thackray Helen M. | SVP Clinical Development, CMO | Sep 18, 2017 | Sale | $13.00 | 2,000 | 26,000 | 150,615 | Sep 18, 2017, 06:15 PM |
GLYC | | GLYCOMIMETICS INC | Thackray Helen M. | SVP Clinical Development, CMO | May 25, 2017 | Sale | $15.57 | 2,000 | 31,140 | 152,615 | May 30, 2017, 04:07 PM |
GLYC | | GLYCOMIMETICS INC | Thackray Helen M. | SVP Clinical Development, CMO | May 19, 2017 | Sale | $12.14 | 2,000 | 24,280 | 154,615 | May 22, 2017, 09:23 PM |
GLYC | | GLYCOMIMETICS INC | Thackray Helen M. | VP Clinical Development, CMO | Oct 03, 2016 | Sale | $7.00 | 4,000 | 28,001 | 156,715 | Oct 04, 2016, 04:22 PM |
GLYC | | GLYCOMIMETICS INC | Thackray Helen M. | VP Clinical Development, CMO | Jul 20, 2016 | Sale | $8.00 | 2,000 | 16,000 | 160,615 | Jul 21, 2016, 05:27 PM |
GLYC | | GLYCOMIMETICS INC | Thackray Helen M. | VP Clinical Development, CMO | Jul 05, 2016 | Sale | $7.01 | 10,136 | 71,053 | 169,411 | Jul 06, 2016, 05:07 PM |
GLYC | | GLYCOMIMETICS INC | Thackray Helen M. | VP Clinical Development, CMO | Jul 06, 2016 | Sale | $6.68 | 6,796 | 45,397 | 162,615 | Jul 06, 2016, 05:07 PM |
GLYC | | GLYCOMIMETICS INC | Thackray Helen M. | VP Clinical Development, CMO | Jul 01, 2016 | Sale | $7.40 | 5,068 | 37,503 | 179,547 | Jul 06, 2016, 05:07 PM |